| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 04/06/2017 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Acquires Exclusive License to Patented Ophthalmic Formulation for Dry Eye Disease | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/29/2017 | 6:03AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/22/2017 | 5:30PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/22/2017 | 8:06AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/22/2017 | 8:00AM | PR Newswire (US) | Imprimis Pharmaceuticals to Raise $3.1 Million in Registered Direct Offering | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/21/2017 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/21/2017 | 4:15PM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/21/2017 | 4:08PM | PR Newswire (US) | Imprimis Pharmaceuticals Announces Fourth Quarter and Year-End 2016 Financial Results | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/20/2017 | 8:30AM | PR Newswire (US) | Peer-Reviewed Paper Demonstrates the Benefits of Dropless Cataract Surgery® | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/14/2017 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/07/2017 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2016 Financial Report Conference Call and Webcast on Marc... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 02/23/2017 | 5:26PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 02/17/2017 | 5:17PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 02/17/2017 | 8:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 02/16/2017 | 4:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 02/16/2017 | 8:00AM | PR Newswire (US) | Imprimis Pharmaceuticals Begins Dispensing from FDA-Registered 503B Outsourcing Facility | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 02/14/2017 | 5:58PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 01/31/2017 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 01/30/2017 | 5:02PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 01/23/2017 | 5:17PM | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 12/30/2016 | 2:35PM | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (d) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 12/29/2016 | 8:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 12/23/2016 | 4:16PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 12/21/2016 | 4:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 12/21/2016 | 4:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 12/21/2016 | 4:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 12/21/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals and FocusScript Partner to Exclusively Offer the Correct Compound™ Program | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 12/19/2016 | 4:30PM | PR Newswire (US) | Imprimis Pharmaceuticals Announces $9.8 Million Private Placement of Units | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 11/17/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Ranked 12 on Deloitte's 2016 Technology Fast 500™ List of Fastest Growing Companies in North Ameri... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |